Pharming Group N.V.
PHGUF
$0.90
$0.1113.92%
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 167.89M | 160.32M | 213.42M | 197.57M | |
| Total Receivables | 50.17M | 51.12M | 42.62M | 40.52M | |
| Inventory | 55.72M | 59.19M | 56.76M | 53.44M | |
| Prepaid Expenses | 4.65M | -- | 3.54M | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | 212.00K | |
| Total Current Assets | 278.44M | 270.63M | 316.34M | 291.74M | |
|
|
|||||
| Total Current Assets | 278.44M | 270.63M | 316.34M | 291.74M | |
| Net Property, Plant & Equipment | 24.13M | 30.72M | 33.47M | 37.48M | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | 61.04M | 66.57M | 71.27M | 69.85M | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 32.14M | 40.64M | 31.38M | 28.16M | |
| Total Assets | 399.99M | 415.93M | 462.85M | 436.47M | |
|
|
|||||
| Total Accounts Payable | 10.10M | 72.97M | 16.02M | 62.54M | |
| Total Accrued Expenses | 53.22M | -- | 50.27M | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 7.19M | 6.97M | 5.44M | 5.52M | |
| Total Finance Division Other Current Liabilities | 3.28M | -- | 6.23M | -- | |
| Total Other Current Liabilities | 3.28M | -- | 6.23M | -- | |
| Total Current Liabilities | 73.80M | 79.94M | 77.97M | 68.06M | |
|
|
|||||
| Total Current Liabilities | 73.80M | 79.94M | 77.97M | 68.06M | |
| Long-Term Debt | 78.15M | 87.32M | 136.60M | 129.73M | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 26.97M | 27.73M | 29.51M | 28.73M | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | 178.92M | 194.99M | 244.07M | 226.53M | |
|
|
|||||
| Common Stock & APIC | 496.76M | 494.60M | 486.10M | 483.63M | |
| Retained Earnings | -287.92M | -273.66M | -265.50M | -273.69M | |
| Treasury Stock & Other | 12.23M | -- | -1.82M | -- | |
| Total Common Equity | 221.06M | 220.94M | 218.78M | 209.94M | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | 221.06M | 220.94M | 218.78M | 209.94M | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 221.06M | 220.94M | 218.78M | 209.94M | |
|
|
|||||
